Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anesthesia
Sugammadex Study First To Show Rapid Reversal of Profound Rocuronium-induced Muscle Relaxation Is Possible
November 15th, 2008
Schering-Plough Corp., (NYSE: SGP) announced that a study published in the November 2008 issue of the medical journal, Anesthesiology (Vol. 109, No. 5)1 demonstrated that sugammadex produced a significantly more rapid recovery from profound rocuronium-induced muscle relaxation than the conventional reversal agent neostigmine. Importantly, this is the first comparative study to demonstrate that rapid reversal of profound rocuronium-induced muscle relaxation is possible. In the study, the median time to recovery was 2.7 minutes in the sugammadex group versus 49.0 minutes in the neostigmine group. Sugammadex is a novel selective relaxant binding agent that...
Source: Law & Health Weekly (2008-11-15)
|
